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ABSTRACT 
Determination of the transcriptional activity of t he  B-adrenoceptor (8- 
AR) gene in human mononuclear leucocytes (MNL) may provide 
important information concerning variations in receptor expression in 
clinical studies. W e  used a new method with highly fluorochrome- 
labeled gene. probes for in situ hybridization which allows a rapid 
detection of mRNA at  the  cellular level. MNL from venous blood of 
healthy volunteers were permeabilized, fixed and attached to  adhesive 
glass slides. After incubation with fluorochrome-labeled cloned hamster 
OAR-DNA probes the  amount of DNA-mRNA hybrids formed in the 
cytoplasm of individual cells was analyzed by rnicrofluorimetry of 
specifically bound fluorochrorne. In nine of ten normal subjects studied 
so fa r  a fraction of OAR-mRNA positive MNL could be detected. 
The proportion of positive cells as well as their signal intensity 
revealed a high interindividual variance. 
INTRODUCTION 
Mononuclear leucocytes (MNL) from human peripheral blood 
contain a homogeneous population of B2-adrenoceptors (13-AR) (1,2). 
They are  often employed as a tissue model t o  monitor variations in 
the expression of the  8-AR-protein which can be  determined 
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quantitatively by radioligand binding techniques (1-4). Various studies 
have demonstrated changes in binding characteristics of the  receptor 
protein under physiological (5,6) and pathological conditions such as 
hypertensive (7-1 l ) ,  asthmatic (12-14) and leukemic (15,161 diseases. In 
this connection the  question arises whether the  altered receptor- 
expression is due to  variations in the degree of gene activation and/or 
other mechanisms. Therefore quantification of the transcriptional 
product, t he  mRNA, may contribute important information concerning 
the  nature of such variations a t  the  cellular level. 
Biochemical methods routinely used for investigation of mRNA, such as 
blot hybridization, require large and uniform cell populations for 
analysis and provide information only for whole populations, not for 
individual cells (17). In situ hybridization, in contrast, is applicable to  
relatively small cell populations (18) and can also yield results in 
heterogeneous populations such as MNL. Moreover i t  allows for 
identification and localization of the mRNA of interest in individual 
cells. Conventional methods using radioactively labeled gene probes a re  
hazardous to  handle and time-consuming, require special precautions, 
and do not provide quantitative results. Fluorochrome labeled gene 
probes on the  other hand are  easy to  t race  by fluorescence microscopy 
and their use offers the  possibilty of quantifying the  results (19-22). 
W e  have adapted this method to  quantify the transcriptional activity 
of the 13-AR gene in human MNL. The results from 10 normalsubjects 
studied so fa r  a re  presented. 
MATERIALS 
DNA probes employed in this study were derived from the 
expression vector for the hamster 8-AR pSVi3AR (complete plasmid or 
HIND 111-fragment) (23,241 which was kindly provided by R. Dixon 
(Merck Sharp & Dohme Research Laboratories, W e s t  Point, Penns., 
USA). As control we used the plasmid pSVL alone or salmon sperm 
DNA (Boeringer Mannheim, Stockholm). 
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Hybridization buffer consisted of mol/l TRIS HCI, pH 7.5, l ~ l O - ~  
mol/l EDTA, 6x10-2 mol/l NaCl, 0.02% Ficoll and 0.002% 
polyvinylpyrollidone. Phosphate buffered saline solution ( P E )  contained 
1 . 4 ~ 1 0 - ~  mol/l NaCI, 1 ~ 1 0 - ~  mol/l sodium phosphate, pH 7.2; SSC 
buffer contained 1.5~10-1 mol/l NaCl and 1 . 5 ~ 1 0 - ~  mol/l sodium 
citrate,  pH 7.5. Fluorescein isothiocyanat (FITC) was obtained from 
Fluka (Buchs, Switzerland), polyethyleneimine (PEI) from Serva 
(Heidelberg, FRG); deionized formamide and buffer substances were 
from Sigma chemicals or Merck (Darmstadt, FRG). 
METHODS 
Labeling of DNA 
Fluorescein isothiocyanate (FITC) was conjugated to  the  synthetic 
polypeptide polyethyleneimine (PEI) a t  an FITC/PEI ratio of 9 pg/5 mg 
as previously described (21,25). The degree of labeling was measured 
by absorbance a t  280 nm for the peptide and 490 nm for fluorescein. 
DNA probes were denatured and then coupled to  the  fluoresceinated 
PEI using 0.04% glutaraldehyde. Excess binding capacity of the  
glutaraldehyde was saturated by adding 0.3% bovine serum albumine 
(BSA). 
Cytological PreDarations 
Venous blood was obtained from the antecubal vein of healthy 
volunteers, 15-53 years old, and anticoagulated with Na2EDTA. 
Immediately thereafter the MNL fraction was harvested by density 
gradient centrifugation (26) using Ficoll-Isopaque and washed twice in 
PBS. lo6 cells were sedimented in 10 pl of PBS. The cell membrane 
was made porous by suspending the cells in 500 p1 of hypotonic 
medium (0.9% trisodium citrate), and five minutes thereafter, the cells 
were fixed t o  retain their shape by adding 500 pl of acetone. Fixation 
was allowed to  proceed a t  least for two hours. The cells were then 
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attached t o  adhesive glass slide areas (Superior, Bad Mergetheim, FRG) 
a t  a density allowing a t  least 3 cell diameters of free space between 
individual cells. 
In Situ Hybridization 
Hybridization reactions were carried out with a modified method 
of Fournier et al. (27). 10 01 of a dilution of the  fluorochrome labeled 
DNA-probe in hybridization buffer (10 ng/lO cells) was added to each 
cell preparation on the glass slides. Reactions were sealed under 
coverslips using a vulcanizing glue and the slides were incubated for 
48 to  72 hours in a humidified athmosphere a t  37°C. The slides were 
then unsealed in SSC buffer, washed once in hybridization buffer 
containing 50% deionized formamide and once again in the 
hybridization buffer without formamide. They were then washed in 
SSC, covered with one drop of glycerine, and the fluorescence 
measured by microfluorimetry. 
Measurements 
Measurements were performed on a Leitz Orthoplan microscope 
photometer MPV 2 equipped with a Ploem optique for fluorescein 
illumination. Cells were adjusted into a measuring diaphragm under 
visual control and excited (480 nm) individually for 0.5 sec. 
Fluorescence intensity was detected by a phototube, and values were 
recorded, transferred to a Commodore CM 8032 and stored on a floppy 
disk. Relative intensity values were standardized with an external 
fluorescence standard. Background measurements were performed on 
cell-free spaces adjacent to the cells and subtracted automatically 
from the total cellular fluorescence value. Corrected net values were 
plotted as a frequency distribution diagram. Specific fluorescence 
intensity was calculated from the difference between the signals of 
LIAR- and control probes. At  least 100 cells were analyzed per sample. 
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RESULTS AND DISCUSSION 
The reported method was developed and standardized in various 
studies on quantitation of B- and T-lymphocyte antigene-receptor 
mRNAs in MNL of normal donors and leukemic pat ients  (19-22). I t  
allows a more  rapid and exac t  discrimination between background and 
specific signals than with radioactively labeled probes, especially in t h e  
low intensity range. Even minority populations of cells c a n  b e  
de tec ted ,  s ince for  a given to ta l  amount of mRNA, one c a n  distinguish 
whether all cells express low levels or only a fraction of cells 
expresses high levels (19-22). 
W e  now have applied this technique t o  quantify t h e  mRNA coding for  
I3-ARs in MNL at  t h e  individual cel l  level. Conditions for  hybridization 
were  optimized empirically using t h e  maximal signal to background 
ratio. 
Ten normal subjects have been studied so far. In 9 cases R-AR-mRNA 
could be  detected in isolated MNL. In these  cases  t h e  proportion of 
positive cells as  well as their signal intensity (i.e. transcriptional 
activity) revealed a high interindividual variance. A t  least two 
subpopulations became evident: a larger population of R-AR-mRNA- 
negative cells (60-97%) with a fluorescence intensity distribution peak 
in t h e  range of t h e  negative control (background binding always being 
assayed with an unrelated fluorochrome labeled probe) and a second 
smaller R-AR-mRNA positive population (3-40% cells with higher 
fluorescence-intensities in t h e  range of 1000 t o  2000 bound probe- 
molecules). Four cases revealed a n  additional population of uncertain 
positive cells which was not sufficiently distinguishable f rom t h e  
negative population by intensity (FIG. 1). Accumulated resul ts  f rom all 
studied subjects a r e  shown in TABLE 1. 
These resul ts  demonstrate  t h a t  in healthy subjects only a fract ion of 
MNL of peripheral blood express mRNA encoding for  S-ARs. Work is 
in progress in order  t o  identify by double labeling with sur face  
markers  and gene probes t h e  cell population t h a t  expresses t h e  recep- 
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FIG. 1. Fluorescence intensity distribution of individually measured 
cells f rom 3 normal subjects hybridized with t h e  FITC-labeled OAR- 
DNA fragment  or salmon sperm DNA (controls) (relative fluorescence 
intensities re la ted t o  an external fluorescence standard and corrected 
from background fluorescence). In panel A all cells are BAR-mRNA 
negative. Panel B reveals a large population of negative and a small 
fraction of positive cells. Panel C shows between positive and negative 
cells a third f ract ion of uncertain positive cells. Jo
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(age, sex: 
rn=male) 
1 137y.,m) 
2 (39y.,f) 
479  
BAR-mRNA positive cells uncertain positive cells 
p r o p o r t i o n  frequency peak proportion frequency peal 
mRNA-conc. at mRNA-conc . at 
[%I [molec./celll [%I [molec./cell] 
14 1500 38 500 
38 1000 --  -- 
TABLE 1. 
OAR-gene Expression in MNL of 10 Healthy Subjects 
tor mRNA. Further  investigations will show whether t h e  O-AR-mRNA- 
positive fract ion of  MNL is related t o  distinct subpopulations (e.g. B- 
or T-cells) and whether variations can  b e  de tec ted  under physiological 
or pathological conditions. 
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